KAIST researchers have developed new technology that can transform colon cancer cells into normal-like cells. Led by Professor Kwang-Hyun Cho, the study identified key molecular switches using computer modeling. Experiments confirmed the findings, suggesting this approach could address severe side effects and recurrence associated with traditional cancer treatments.